March 19, 2025

Holland & Knight Health Dose: March 19, 2025

Sarah Starling Crossan | Jordan K. Brossi

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

Looking Ahead: First Break for Congress
Hearings This Week: None Scheduled
Week in Review: Senate Passes CR to Avoid Shutdown
Dr. Mehmet Oz Appeared Before Senate Finance Committee for Confirmation Hearing
Executive Order Updates
Additional EOs Issued by Previous Administration Rescinded
Make America Healthy Again (MAHA) Commission Holds First Meeting
Personnel Updates
Reconciliation
HALT Fentanyl Act (S. 331) Passes Senate
Congressional Doctors Caucus Added to Caucus List, Criticizes Physician Fee Schedule Cuts
CDC Workgroup Announced by HELP Committee Chair Cassidy
Tariffs on Mexico, Canada and China Update
Deadline to Register for CMS Medicare Drug Price Negotiation Public Events Extended
CMMI Models Canceled
HHS Eliminates 6 Regional Offices for Legal Staff
WHO Designates Collaborating Centre on AI for Health Governance